poziotinib
luye group,spectrum pharmaceuticals,zenith capital corporation
['nsclc', 'sclc', 'poziotinib', 'zenith']
#asco22 abstract 3051 (board 43 today) shows serial #liquidbiopsy in pts with #her2 nsclc receiving poziotinib in zenith20 trial. drop in ctdna correlates with response. rise heralds progression. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him